Site-specific activation of dopamine and serotonin transmission by aniracetam in the mesocorticolimbic pathway of rats

Brain Research

Volumn 897, Issue 1-2, 2001, Pages 82-92

  Nakamura, Kazuo ^a   Shirane, Masatoshi ^a   Koshikawa, Noriaki ^b  

^a NIPPON ROCHE RESEARCH CENTER   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

Aniracetam; Dopamine; Mesocorticolimbic pathway; Microdialysis; Serotonin; Stroke prone spontaneously hypertensive rat

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; ANIRACETAM; DOPAMINE; HOMOVANILLIC ACID; NICOTINIC RECEPTOR; SEROTONIN;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATECHOLAMINE BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; HIPPOCAMPUS; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; RAT STRAIN; SEROTONIN RELEASE; SEROTONINERGIC TRANSMISSION; STRAIN DIFFERENCE; STROKE;

AMYGDALA; ANIMALS; BEHAVIOR, ANIMAL; CEREBROVASCULAR ACCIDENT; DOPAMINE; HIPPOCAMPUS; MALE; MICRODIALYSIS; MOTOR ACTIVITY; NEURAL PATHWAYS; NOOTROPIC AGENTS; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PROSENCEPHALON; PYRROLIDINONES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SEROTONIN; SYNAPTIC TRANSMISSION;

EID: 0035815514     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)02096-0     Document Type: Article

References (67)

1. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram
2. Escapable and inescapable stress differentially alter extracellular levels of 5-HT in the basolateral amygdala of the rat
3. Modulation of dopamine efflux in the nucleus accumbens after cholinergic stimulation of the ventral tegmental area in intact, pedunculopontinetegmental nucleus-lesioned, and laterodorsal tegmental nucleus-lesioned rats
4. Expression of messenger RNAs encoding ionotropic glutamate receptors in rat brain: Regulation by haloperidol
5. Reduction of CSF monoamine metabolites in poststroke depression: A preliminary report
6. Stress, depression and the mesolimbic dopamine system
7. Mechanisms of emotional arousal and lasting declarative memory
8. The neuropsychiatry of stroke
9. Regional brain function, emotion and disorders of emotion
10. Stress-induced activation of prefrontal cortex dopamine turnover: Blockade by lesions of the amygdala
11. Stress selectively increases fos protein in dopamine neurons innervating the prefrontal cortex
12. The role of afferents to the ventral tegmental area in the handling stress-induced increase in the release of dopamine in the medial prefrontal cortex: A dual-probe microdialysis study in the rat brain
13. The amygdala modulates prefrontal cortex activity relative to conditioned fear
14. The effect of the selective reversible acetylcholinesterase inhibitor E2020 on extracellular acetylcholine and biogenic amine levels in rat cortex
15. The neurochemistry of vascular dementia
16. Role of 5-HT in stress, anxiety, and depression
17. Central serotonergic uptake mechanisms in hypertensive rats: Effects of clonidine and centhaquin
18. Depression in acute and chronic aphasia: Symptoms, pathoanatomical-clinical correlations and functional implications
19. Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination
20. Aniracetam reduces glutamate receptor desensitization and slows the decay of fast excitatory synaptic currents in the hippocampus
21. Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors
22. Release of serotonin in the locus coeruleus of normotensive and spontaneously hypertensive rats (SHR)
23. Behavioral and neurochemical effects of cholinergic and dopaminergic agonists administered into the accumbal core and shell in rats
24. Up-regulation of dopamine receptors in the brain of the spontaneously hypertensive rat: An autoradiographic analysis
25. Aniracetam ameliorates impaired pre- and post-synaptic cholinergic indices in gerbil hippocampus induced by transient forebrain ischemia
26. Changes in levels of monoamines and their metabolites in incompletely ischemic brains of spontaneously hypertensive rats
27. Neuroanatomic substrates of depression in the elderly
28. Anxiolytic, anti-impulsive and anti-depressive properties of aniracetam in rodents
29. Methylphenidate and nortriptyline in the treatment of poststroke depression: A retrospective comparison
30. Brain mechanisms of emotion and emotional learning
31. Mesocorticolimbic dopaminergic network: Functional and regulatory roles
32. Serotonin receptors and their function in sleep, anxiety disorders and depression
33. Metabotropic glutamate receptors modulate serotonin release in the rat periaqueductal gray matter
34. Pharmacology of aniracetam: A novel pyrrolidinone derivative with cognitive enhancing activity
35. 2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors
36. Spontaneous remission of post-stroke depression and temporal changes in cortical S2-serotonin receptors
37. Central cholinergic pathways in the rat: An overview based on alternative nomenclature (Ch1-Ch6)
38. Dopamine receptors: From structure to function
39. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats
40. Serotonergic mechanisms involved in the attentional and vigilance task performance of rats and the palliative action of aniracetam
41. Impulsivity and AMPA receptors: Aniracetam ameliorates impulsive behavior induced by a blockade of AMPA receptors in rats
42. Scopolamine model of delirium in rats and reversal of the performance impairment by aniracetam
43. Apomorphine-induced hypo-attention in rats and reversal of the choice performance impairment by aniracetam
44. Activation of the reticulothalamic cholinergic pathway by the major metabolites of aniracetam
45. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area
46. Ventral tegmental (A10) system: Neurobiology. 1. Anatomy and connectivity
47. Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat
48. Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: An in situ hybridization study
49. Clinical usefulness of aniracetam for psychiatric symptoms in patients with cerebrovascular disorders: Placebo controlled double-blind trial
50. The role of stress in the pathophysiology of the dopaminergic system
51. 'Behavioral despair' test predicts stress ulcer in WKY rats
52. Metabotropic glutamate receptor agonist (1S, 3R-ACPD) increased frontal cortex dopamine release in aged but not in young rats
53. Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells
54. Effects of systemic nicotine on serotonin release in rat brain
55. 3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of attention-deficit hyperactivity disorder
56. Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD)
57. Animal models of vascular dementia with emphasis on stroke-prone spontaneously hypertensive rats
58. Cholinergic neurons of the laterodorsal tegmental nucleus: Efferent and afferent connections
59. N-methyl-d-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens
60. Group II metabotropic glutamate receptors are a common target of N-anisoyl-GABA and 1S, 3R-ACPD in enhancing ACh release in the prefrontal cortex of freely moving SHRSP
61. Imaging of the serotonergic system: Interactions of neuroanatomical and functional abnormalities of depression
62. Effects of local and repeated systemic administration of (-)nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine, and serotonin in rat cortex
63. Influence of AMPA/kainate receptors on extracellular 5-hydroxytryptamine in rat midbrain raphe and forebrain
64. Cholinergic changes in the hippocampus of stroke-prone spontaneously hypertensive rats
65. Anatomy of the serotonergic system
66. Tonic desensitization of hippocampal alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors regulates 5-hydroxytryptamine release in vivo